@article{andre:hal-03657929,
TITLE = {Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study},
AUTHOR = {Andre, Thierry and Tougeron, David and Piessen, Guillaume and de La Fouchardiere, Christelle and Louvet, Christophe and Adenis, Antoine and Jary, Marine and Tournigand, Christophe and Aparicio, Thomas and Desrame, Jerome and Lievre, Astrid and Garcia-Larnicol, Marie-Line and Pudlarz, Thomas and Henriques, Julie and Cohen, Romain and Lefevre, Jeremie and Svrcek, Magali},
URL = {https://hal.science/hal-03657929},
JOURNAL = {Journal of Clinical Oncology},
PUBLISHER = {American Society of Clinical Oncology},
VOLUME = {40},
NUMBER = {4},
PAGES = {244-244},
YEAR = {2022},
MONTH = Feb, DOI = {10.1200/JCO.2022.40.4\_suppl.244},
HAL_ID = {hal-03657929},
HAL_VERSION = {v1},
}